Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) Studies

Sponsor: Pfizer

Sponsor score: 60
Inactive

ClinicalTrials ID:NCT05226871

Patient View

This open-label study provides continued access to palbociclib and other treatments (cetuximab, fulvestrant, letrozole) for participants benefiting from a Pfizer-sponsored parent study. Eligible participants must comply with reproductive criteria, scheduled visits, and study procedures, and provide informed consent. The study focuses on monitoring the safety of these interventions.

Patient Parameters

Program Overview

The purpose of this clinical trial is to provide study medicine(s) and learn about their safety. This study is seeking participants who:

  • Have benefited from ongoing study treatment as determined by the study doctor in a Pfizer-sponsored palbociclib Parent Study
  • Must agree to follow the reproductive criteria
  • Are willing and able to comply with all scheduled visits, treatment plans, and other study procedures
  • Can give signed informed consent documents

Participants in this study will continue to receive treatment as they were in the parent study. The time by which participants will take part in this study is retrospective (after completed parent study). We will examine the experiences of people receiving the study medicine(s). This will help us determine if the study medicine(s) are safe. During this time, the participants will be monitored for the safety of the study medicine(s).

Description

This is an open-label study to provide continued access to treatment for eligible participants who continue to derive clinical benefit as determined by the investigator from study intervention(s) in a Pfizer-sponsored palbociclib clinical study (Parent Study)

Eligibility Criteria

Inclusion Criteria

  • Any participant who is receiving study treatment and deriving clinical benefit as determined by the investigator in a Pfizer-sponsored palbociclib Parent Study
  • Participants must agree to follow the reproductive criteria
  • Participants who are willing and able to comply with all scheduled visits, treatment plans, and other study procedures
  • Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent document and protocol

Exclusion Criteria

  • Any medical reason that, in the opinion of the investigator or sponsor, precludes the participant from inclusion in the study

Get This Program In Your Inbox

You can sign up and apply your patients for this program.